International Journal of Clinical Pharmacy

, Volume 36, Issue 4, pp 693–696 | Cite as

Patient characteristics among users of analgesic over-the-counter aspirin in a Danish pharmacy setting

  • Anton Pottegård
  • Ann-Katrine Kviesgaard
  • Ulrik Hesse
  • Søren Ilsøe Moreno
  • Jane Møller Hansen
Short Research Report


Background Use of over-the-counter (OTC) high-dose acetylsalicylic acid (ASA) is a risk factor for experiencing gastric bleeding. However, more detailed knowledge on the characteristics of users of OTC ASA is needed. Objective To characterise users of OTC high-dose ASA in a Danish pharmacy setting. Method We conducted an interview based survey among users of OTC high-dose ASA. Questions were asked regarding: (1) demographic characteristics; (2) use patterns; (3) knowledge about adverse events; (4) risk factors for experiencing gastric bleeding; (5) reasons for choosing an ASA-containing medicine; and (6) whether their GP was informed on their use of high-dose ASA. Results One-hundred-seventeen interviews were completed. Nineteen percent and 37 % used high-dose ASA on a daily or weekly basis respectively. Sixty-eighth percent found high-dose ASA to be more effective than other analgesics. Fourty-seven percent had one or more risk factors for experiencing ulcer bleeding, most commonly age >60 years (32 %) and previous peptic ulcer (9 %). The most well-known adverse events were abdominal pain (32 %) and peptic ulcer (26 %). The most common source of information was friends and family (32 %). Conclusion A large proportion of users of high-dose ASA have risk factors for experiencing gastric bleeding. Health-care professionals needs to provide more information on potential adverse events.


Aspirin Denmark Drug toxicity Gastric ulcer Nonprescription drugs Non-steroidal anti-inflammatory agents 



The authors wish to thank the pharmacists and assistant pharmacists at the participating pharmacies for their aid in recruiting interview subjects for the study. Tora Hammar is acknowledged for valuable comments on the manuscript.


No specific funding was obtained for this study.

Conflicts of interest

The authors have no relevant conflicts, financial or otherwise, to declare.


  1. 1.
    Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993–2002: a population-based cohort study. Am J Gastroenterol. 2006;101:945–53.PubMedCrossRefGoogle Scholar
  2. 2.
    Lanas A, Garcia-Rodriguez LA, Arroyo MT, Gomollon F, Feu F, Gonzalez-Perez A, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55:1731–8.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Vestergard A, Bredahl K, de Muckadell OB, Pedersen OB, Hansen JM, et al. Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid. Ugeskr Laeger. 2009;171:235–9.PubMedGoogle Scholar
  4. 4.
    Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ. 2006;333:726.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995;310:827–30.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    The Danish National Institute for Health Data and Disease Control (Statens Serum Insititut).; Cited 24/7/2013.
  7. 7.
    Lanas A. A review of the gastrointestinal safety data—a gastroenterologist’s perspective. Rheumatology. 2010;49(Suppl 2):3–10.CrossRefGoogle Scholar
  8. 8.
    Lanas A, McCarthy D, Voelker M, Brueckner A, Senn S, Baron JA. Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds—gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. Drugs R D. 2011;11:277–88.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Delaney JA, Biggs ML, Kronmal RA, Psaty BM. Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf. 2011;20:83–9.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Pigeon P, Robillard E, Clarke GD, Burnett I. A prospective survey to compare the suitability profiles of over-the-counter ibuprofen and paracetamol use in a French general practitioner-controlled population. Clin Drug Investig. 2006;26:575–81.PubMedCrossRefGoogle Scholar
  11. 11.
    Institute for Rational Pharmacotherapy. [The National Recommendation List—N02B Weak Analgesics] (in Danish); Cited 8/11/2013.

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Anton Pottegård
    • 1
    • 2
  • Ann-Katrine Kviesgaard
    • 3
  • Ulrik Hesse
    • 4
  • Søren Ilsøe Moreno
    • 5
  • Jane Møller Hansen
    • 6
  1. 1.Clinical Pharmacology, Institute of Public HealthUniversity of Southern DenmarkOdense CDenmark
  2. 2.Department of Clinical Chemistry and PharmacologyOdense University HospitalOdense CDenmark
  3. 3.Sct. Clemens PharmacyNykøbing MorsDenmark
  4. 4.Data Deliveries and Medicinal Products Statistics, Sector for National Health Surveillance and ResearchStatens Serum InstitutCopenhagen SDenmark
  5. 5.Institute for Rational PharmacotherapyDanish Health and Medicines AuthorityCopenhagen SDenmark
  6. 6.Department of Medical GastroenterologyOdense University HospitalOdense CDenmark

Personalised recommendations